REDWOOD CITY, Calif., June 04, 2020 (GLOBE NEWSWIRE) — Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage gene therapy company targeting […]
Company Ended First Quarter with $217 Million in Cash and Marketable Securities and No Debt Company Provides COVID-19 Business UpdateLYNNWOOD, Wash., […]